Clinical Trial Update: Clinical Study of Autologous Stem Cell Transplantation + Anti-CD19 CAR T Cells for B-cell Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating autologous stem cell transplantation combined with anti-CD19 CAR T cells for B-cell lymphoma is underway, with current statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma

Drugs mentioned

• Anti-CD19 CAR T cells (CD19-directed CAR T cells)
• Autologous stem cell transplantation (autologous stem cell transplantation)

Snippet

Sponsor: The Affiliated Hospital of Xuzhou Medical University | Conditions: B-cell Lymphoma | Phase 2 | Status: UNKNOWN